Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |